Efficiency of Adding Omalizumab to Standard Therapy for Children with Recurrent Spontaneous Urticaria: Comparative Observational Study

Background. Recurrent spontaneous urticaria (RSU) is rare in children, thus, it is debilitating condition that always requires treatment. There are several limitations on the drugs use in children with RSU. Omalizumab is the effective medication for achieving the control of RSU, used in adolescents...

Olles dieđut

Bibliográfalaš dieđut

Váldodahkkit:	Vera G. Kalugina, Elena A. Vishneva, Leyla S. Namazova-Baranova
Materiálatiipa:	Artigo
Giella:	Russo
Almmustuhtton:	Union of pediatricians of Russia 2020-08-01
Ráidu:	Педиатрическая фармакология
Fáttát:	recurrent urticaria antihistamine omalizumab spontaneous remission
Liŋkkat:	https://www.pedpharma.ru/jour/article/view/1858
Fáddágilkorat:	Lasit fáddágilkoriid Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!